Iakovleva Irina, Brännström Kristoffer, Nilsson Lina, Gharibyan Anna L, Begum Afshan, Anan Intissar, Walfridsson Malin, Sauer-Eriksson A Elisabeth, Olofsson Anders
Department of Medical Biochemistry and Biophysics, Umeå University , 901 87 Umeå, Sweden.
Department of Chemistry, Umeå University , 901 87 Umeå, Sweden.
J Med Chem. 2015 Aug 27;58(16):6507-15. doi: 10.1021/acs.jmedchem.5b00544. Epub 2015 Aug 11.
The plasma protein transthyretin (TTR) is linked to human amyloidosis. Dissociation of its native tetrameric assembly is a rate-limiting step in the conversion from a native structure into a pathological amyloidogenic fold. Binding of small molecule ligands within the thyroxine binding site of TTR can stabilize the tetrameric integrity and is a potential therapeutic approach. However, through the characterization of nine different tetramer-stabilizing ligands we found that unspecific binding to plasma components might significantly compromise ligand efficacy. Surprisingly the binding strength between a particular ligand and TTR does not correlate well with its selectivity in plasma. However, through analysis of the thermodynamic signature using isothermal titration calorimetry we discovered a better correlation between selectivity and the enthalpic component of the interaction. This is of specific interest in the quest for more efficient TTR stabilizers, but a high selectivity is an almost universally desired feature within drug design and the finding might have wide-ranging implications for drug design.
血浆蛋白转甲状腺素蛋白(TTR)与人类淀粉样变性有关。其天然四聚体组装体的解离是从天然结构转变为病理性淀粉样折叠的限速步骤。小分子配体在TTR的甲状腺素结合位点内的结合可以稳定四聚体完整性,是一种潜在的治疗方法。然而,通过对九种不同的四聚体稳定配体的表征,我们发现与血浆成分的非特异性结合可能会显著损害配体的功效。令人惊讶的是,特定配体与TTR之间的结合强度与其在血浆中的选择性并无很好的相关性。然而,通过使用等温滴定量热法分析热力学特征,我们发现选择性与相互作用的焓成分之间存在更好的相关性。这在寻找更有效的TTR稳定剂方面具有特别的意义,但高选择性几乎是药物设计中普遍期望的特征,这一发现可能对药物设计产生广泛影响。